Company intelligence / Profile preview

Profil

Neuss/Düsseldorf area, North Rhine-Westphalia, Germanyprofil-global.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Not applicable; acts as a CRO conducting early-phase through late-phase clinical studies for sponsors. Renowned for expertise in glucose clamp studies and innovative trial designs in diabetes/metabolism.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: small moleculesbiologicsmedical devices related to metabolic diseases and diabetes
Industry: Contract Research Organization

Partnerships

Collaborates with major pharma/biotech companies developing diabetes/metabolic drugs

Beyond the preview

Go deeper on Profil.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Profil.

Explore the full profile